Martine Zimmermann

Company: Ipsen

Job title: Senior Vice President, Head of Regulatory, R&D Quality

Bio:

Dr Zimmermann has over 25 years of combined R&D and global regulatory strategy experience. She joined Alexion Pharmaceuticals (part of AstraZeneca since 2021) in 2009 and has since then been dedicated to the registration of several orphan medicinal products across the globe, as well as to the shaping of the regulatory environment for medicines under development for rare diseases. Prior to Alexion Pharmaceuticals, Dr Zimmermann held numerous R&D and regulatory roles in companies such as Aventis (now Sanofi), Servier and H. Lundbeck A/S. Dr Zimmermann also serves currently as a Director in the Board of Inventiva Pharma, and previously in the Board of Caelum Biosciences (now part of AstraZeneca). Dr. Zimmermann has also held several external roles and is currently a member of the Board of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Martine has been a champion of diversity, equality, inclusion and belonging, having been recognized by the Healthcare Businesswoman’s Association as a Luminary in 2020, and efforts by serving as an executive sponsor for Alexion’s flagship Women In Leadership (WIL) employee resource group. She received her PharmD from the University Louis Pasteur in Strasbourg, France, and is based in Dublin, Ireland